|
|
||||||||
1 Department of Pediatrics, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213; 2 Departments of Anesthesiology, and Physiology and Biophysics, Mayo Clinic and Mayo Medical School, Rochester, Minnesota 55905; 3 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213; 4 Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213; and 5 Department of Cell Biology and Histology, University of Nijmegen, Nijmegen, The Netherlands
Watchko, Jon F., Monica J. Daood, Gary C. Sieck, John J. LaBella, Bill T. Ameredes, Alan P. Koretsky, and Be
Wieringa. Combined myofibrillar and mitochondrial
creatine kinase deficiency impairs mouse diaphragm isotonic function.
J. Appl. Physiol. 82(5): 1416-1423, 1997.
Creatine kinase (CK) is an enzyme central to cellular high-energy phosphate metabolism in muscle. To characterize the physiological role of CK in respiratory muscle during dynamic contractions, we compared the force-velocity relationships, power, and
work output characteristics of the diaphragm (Dia) from mice with
combined myofibrillar and sarcomeric mitochondrial CK deficiency (CK[
/
]) with CK-sufficient controls (Ctl).
Maximum velocity of shortening was significantly lower in
CK[
/
] Dia (14.1 ± 0.9 Lo/s,
where Lo is
optimal fiber length) compared with Ctl Dia (17.5 ± 1.1 Lo/s)
(P < 0.01). Maximum power was
obtained at 0.4-0.5 tetanic force in both groups; absolute maximum
power (2,293 ± 138 W/m2) and
work (201 ± 9 J/m2) were
lower in CK[
/
] Dia compared with Ctl Dia
(2,744 ± 146 W/m2 and 284 ± 26 J/m2, respectively)
(P < 0.05). The ability of
CK[
/
] Dia to sustain shortening during
repetitive isotonic activation (75 Hz, 330-ms duration repeated each
second at 0.4 tetanic force load) was markedly impaired, with
CK[
/
] Dia power and work declining to zero by 37 ± 4 s, compared with 61 ± 5 s in Ctl Dia. We conclude that combined myofibrillar and sarcomeric mitochondrial CK deficiency profoundly impairs Dia power and work output, underscoring the functional importance of CK during dynamic contractions in skeletal muscle.
respiratory muscle; fatigue; myosin heavy chain
RESPIRATORY MUSCLE FATIGUE is a phenomenon of clinical
importance contributing to the development of ventilatory failure in neonates and adults. The factors predisposing muscle to fatigue are
felt primarily to result from an imbalance between energy supply and
demand (25, 35). The accumulation of energy metabolites in all
probability also plays an important role (1, 6, 8). Alteration of the
capacity of skeletal muscle to produce or sustain ATP levels is thus
likely to affect muscle fatigue resistance. Creatine kinase (CK), an
enzyme central to cellular high-energy phosphate metabolism in muscle,
may be important in this regard. CK catalyzes the following reaction
where
PCr is phosphocreatine and Cr is creatine. The high level of CK
activity found in skeletal muscle ensures that, when consistent
high-energy phosphate production is necessary during repetitive
contractile activity, ATP levels will be maintained at the expense of
PCr. This role of CK as an ATP buffer is widely accepted (18, 33).
Defining a physiological role for CK in skeletal muscle fatigue, however, has been difficult, with prior studies using substrate analogs (10, 16, 17, 20) of Cr to assess the functional consequences of impaired CK activity. These studies have generated disparate results and exclusively examined fatigue under repetitive isometric conditions. The respiratory muscles' capacity to sustain ventilation, however, is determined in large part by its ability to shorten and maintain force during repetitive dynamic contractions (3, 22). Moreover, dynamic contractions are known to have higher energetic demands (9, 12) than those of an isometric nature that should further challenge the CK-PCr system.
In the present study, we took an alternative approach to ascertain the
role of CK in respiratory muscle function by using reverse genetics to
alter CK expression in the intact animal. Specifically, we studied the
diaphragm muscle (Dia) from mice bearing combined null mutations for
the sarcomeric mitochondrial CK (ScCKmit) (27, 28) and myofibrillar CK
(M-CK) genes (32) and determined the effect of this blockade in the CK
system on respiratory muscle function during repetitive isotonic
activation. These ScCKmit/M-CK double-deficient mutant
(CK[
/
]) mice have recently been generated by
using targeted mutagenesis (27). We hypothesized that
CK[
/
] double-deficient Dia would have a marked impairment in shortening capacity, as indexed by decrements in
the extent of muscle shortening, muscle shortening velocity, power, and
work during repetitive isotonic activation, as compared with wild-type
CK-sufficient Dia. Because CK isoforms are structurally associated with
sites of energy consumption [M-CK and actomyosin adenosinetriphosphatase (ATPase) on the myosin heavy chain (MHC)] (33) and isotonic contractile properties are related to myosin isoform
composition, we also determined the effect of CK deficiency on MHC
phenotype.
Mice bearing a null mutation of the ScCKmit
[
/
] gene (27, 28) were interbred with mice
bearing a null mutation of the M-CK gene (32) to generate heterozygotes
for both CK isoforms. Sibling matings of these mice resulted in
the generation of ScCKmit/M-CK double-deficient mutant
CK[
/
] mice, as previously described and
confirmed by polymerase chain reaction analysis (27).
Control and ScCKmit/M-CK double-deficient mice had a mixed
genetic (C57B1/6 × 129/Sv) background. Eleven control (Ctl) and
11 ScCKmit/M-CK double-deficient adult (90-110 days) mice
were used in the study, and the experiments were approved by the
Magee-Womens Hospital Institutional Animal Care and Use Committee.
Animals were anesthetized with pentobarbital sodium (60 mg/kg ip), and
individual segments of diaphragm were excised for
1) in vitro assessment of isometric and isotonic contractile properties,
2) measurement of CK activity, and
3) determination of MHC phenotype.
In vitro measurements. Dia muscle strips (~2 mm wide) were cut from the midcostal region of the right hemidiaphragm, with fiber attachments at the rib and central tendon left intact. The muscle segments were mounted in a vertical tissue chamber, which was constantly perfused with mammalian Ringer solution aerated with 95%O2-5%CO2 and maintained at 37°C. The monitored PO2, PCO2, and pH were 400-460 Torr, 35-40 Torr, and 7.35-7.40, respectively. The costal margin origin of fibers was fixed by use of a vascular clamp mounted in series to a micropositioner near the base of the tissue chamber. A small piece of aluminum foil was glued to the central tendon with cyanoacrylate and then attached to the force transducer (model 300B, Cambridge Technology) via fine wire. This provided a noncompliant attachment to the force transducer and prevented tearing of the central tendon. The muscle bundles were stimulated directly (Grass model S-88 stimulator and current amplifier) by use of monophasic rectangular pulses of cathodal current (1.0-ms duration) delivered through platinum plate electrodes placed ~1 cm apart. Muscle bundles were positioned midway between the two electrodes. To ensure supramaximal stimulation, current was increased by 50% over the current necessary to obtain peak twitch force (~250-300 mA). Muscle fiber length was adjusted incrementally by using a micropositioner until maximal isometric twitch force (Pt) responses were obtained [i.e., optimal fiber length (Lo)]. Twitch contraction (CT) and half relaxation (RT1/2) times were also determined. Maximum tetanic force (Po) was assessed by stimulating the muscle bundle at 75 Hz delivered in a 1-s train. Force and length signals of the Cambridge dual-mode servo-control module were displayed on a digital oscilloscope (model 1602, Gould), digitized at 500 Hz, and stored on a computer disk file. The stimulation paradigm and isotonic afterloaded contractions were controlled by a computer program (LabView 3.1, National Instruments).
Shortening velocities were measured at eight different loads (5-50% of Po) during isotonic afterloaded contractions. Velocities were calculated by computer from the maximum slope of the digitized length signal in the interval between 10 and 30 ms after the beginning of the isotonic shortening phase. Loads were calculated as a fraction of Po based on the force plateau measured during the isotonic contraction. The data were fitted by a modified version (2) of Hill's hyperbolic equation [(V + b)(P/Po + a/Po) = b(1 + a/Po)] (12) by using a least squares technique, and maximum velocity of shortening (Vmax) was calculated from the optimum a/Po and b values as Vmax = b/(a/Po). Vmax is reported in Lo per second. Power was calculated as the product of the isotonic afterload and velocity of shortening and expressed in watts per square meter. Work was calculated as the product of the isotonic afterload and extent of lengthening and expressed in joules per square meter. The maximum power and work were derived from the respective power and work curves over the range of afterloads (5-50% Po) examined.
After the completion of the force-velocity measurements, the muscle was
stimulated repetitively under isotonic conditions (75 Hz in trains of
330-ms duration repeated each second) at 40% Po, the load that produced maximum
power in both CK[
/
] and Ctl animals. Changes
in velocity and extent of Dia shortening, power, and work were
determined during repetitive isotonic activation. The endurance time
(in s) was calculated as the interval between the initiation of
repetitive isotonic activation and the cessation of muscle shortening.
Following the repetitive isotonic activation paradigm,
Lo was
determined, and the stimulated muscle segment was weighed. Muscle
cross-sectional area (CSA) was estimated on the basis of the following
formula: muscle weight
(g)/[Lo
(cm) × 1.056 (g/cm3)]. The estimated
CSA was used to determine specific twitch
(Pt/CSA) and tetanic
(Po/CSA) forces of the
muscle segments.
Determination of CK activity and isoenzyme
distribution. Total CK activity was determined at
25°C by using a coupled enzyme assay (34). The ATP generated by the
CK reaction was used in a hexokinase/glucose-6-phosphate
dehydrogenase-coupled enzyme system, which ultimately yields a reduced
NADP (NADPH) proportional to CK activity (Sigma Diagnostics, St. Louis,
MO). For this analysis, a 5- to 10-mg muscle sample was homogenized for
15 s in a 1:100 (wt/vol) dilution of CK extraction buffer
containing 26 mM tris(hydroxymethyl)aminomethane (Tris), 0.3 M sucrose,
1% NP40, and 20 mM
-mercaptoethanol at pH 8.0. Homogenates were
diluted to 1:100 in extraction buffer. Thirty-microliter aliquots of
diluted homogenate were added to 1 ml of CK assay buffer at 25°C,
containing 130 mM KCl, 10 mM Tris (pH 7.4), 1 mM
MgCl2, 2 mM AMP, 50 µM
diadenosine pentaphosphate, 5 mM glucose, 0.7 mM NADP, 1.5 mM ADP, 9 mM
PCr, 1.3 U of hexokinase, and 0.5 U of glucose-6-phosphate
dehydrogenase. AMP and diadenosine pentaphosphate were included to
inhibit adenylate kinase from producing ATP. The rate increase in
absorbance at 340 nm, due to production of NADPH through the coupled
enzyme reaction, was used to determine CK activity. Care was taken to
make sure that the rate obtained changed linearly with the volume of
homogenate added. Protein content was determined by the Lowry method
(15), and CK activity was expressed as micromoles per milligram protein per minute.
The CK isoenzyme phenotype was resolved electrophoretically (34). Homogenized muscle tissue (as above) was centrifuged for 20 min at 14,000 revolutions/min at 4°C, the supernatant was diluted 1:10 in extraction buffer, and 1 µl of diluted supernatant was added to a 1% agarose gel (Ciba-Corning, Marshfield, MA). Electrophoresis was performed at 120 V for 20 min at 4°C. CK activity was visualized by evenly spreading Cardiotrac CK isoenzyme reagent (90 mM PCr, 60 mM magnesium acetate, 60 mM glucose, 60 mM N-acetyl cysteine, 15 mM AMP, 12 mM ADP, 6 mM NAD, 10 µM diadenosine pentaphosphate, 9,000 U/l hexokinase, and 7,500 U/l glucose-6-phosphate dehydrogenase) on the gel and incubating for 20 min at 37°C. Production of NADPH in the gel was visualized directly with ultraviolet light. The BB, MB, MM, and mitochondrial CK isoforms are readily separated by this electrophoretic technique (34). To determine the relative contributions of individual isoforms to their respective total CK complements, photographs of the gels were taken and analyzed by using a scanning densitometer (GS 300 Hoefer Scientific) and densitometry software (GS 365, Hoefer Scientific) to quantify the area under individual isoform peaks.
Determination of MHC composition.
Myosin for electrophoresis was prepared by scissor-mincing the muscle
tissue in a high salt solution, pH 6.5 at 4°C for 40 min (14).
Extracts were centrifuged and supernatants recovered and treated as
follows. Electrophoresis of MHC isoforms was performed by using the
method of Talmadge and Roy (29). Ten microliters of supernatant were
diluted (1:10) in a low-salt buffer consisting of 1 mM EDTA and 0.1%
2-mercaptoethanol (vol/vol) and stored overnight at 4°C to allow
precipitation of myosin filaments. The filament solution was
subsequently centrifuged to form a pellet, which was then dissolved in
myosin sample buffer (0.5 M NaCl, 10 mM
NaH2PO4)
followed by dilution 1:100 in sodium dodecyl sulfate (SDS) sample
buffer [62.5 mM Tris · HCl, 2% (wt/vol) SDS, 10% glycerol, 5% (vol/vol) 2-mercaptoethanol, and 0.001% (wt/vol) bromophenol blue at pH 6.8]. The samples were
boiled for 2 min and stored at
80°C.
Gels were prepared from a stock solution of 30% acrylamide containing
29.4% (wt/vol) acrylamide and 0.60% (wt/vol)
N,N
-methylene-bis-acrylamide (Bis). Electrophoresis was performed on slabs (18 × 16 cm × 0.75 mm thick) consisting of an 11.5-cm separating gel and a 4.5-cm stacking gel. Separating gels of total concentration of monomer (acrylamide + Bis) (T) = 8% and stacking gels of T = 4% at
percentage of total monomer due to Bis (C) = 2% were used. Volumes of
myosin extract (1-3 µl) containing 500-1,000 ng of
protein/well were loaded on the gels. Electrophoresis (275 V for 3.5 h
then 178 V for 17.5 h) was performed by using a vertical-slab gel unit (SE600, Hoefer Scientific Instruments) with Tris/glycine running buffer
(29) in a cold room maintained at 4°C. Separating gels were silver
stained (14). Monoclonal antibodies were used to identify the specific
MHC bands (MHCslow,
MHCIIa,
MHCIIx,
MHCIIb) separated on
SDS-polyacrylamide gel electrophoresis gels and included 1) antibody BF-32 to
MHCslow and
MHCIIa;
2) antibody SC-71 to MHCIIa;
3) BF-35 to all but
MHCIIx;
4) BF-F3 to
MHCIIb; and
5) RT-D9 to
MHCIIx and
MHCIIb (14). MHC gels were
analyzed by using a scanning densitometer (GS 300 Hoefer Scientific)
and densitometry software (GS 365, Hoefer Scientific) to quantify the
area under individual isoform peaks. These data were used to determine
the relative contributions of individual isoforms to their respective total heavy chain myosin complements.
Statistical analysis. Differences
between groups with respect to animal weight and Dia muscle
characteristics were determined by the unpaired Student's
t-test. Statistical methods also
included a two-way analysis of variance to compare changes in the
velocity and extent of Dia shortening, power, and work as a function of study group and time during repetitive isotonic activations (Minitab Data Analysis Software, Minitab Windows version 9.2, State College, PA)
(21). In the event of a significant analysis of variance, the Duncan
multiple-range test was used as the post hoc analysis to define
differences between control and CK[
/
] groups
at specific times (36). Statistical significance was established a
priori at P < 0.05. Data are
reported as means ± SE.
Physical characteristics and isometric contractile
properties. Animal and Dia characteristics, as well as
Dia isometric contractile properties are presented in Table
1. Animal body weight, Dia Lo, CT,
RT1/2,
Pt/CSA, and
Pt/Po
were not significantly different between
CK[
/
] and Ctl animals (Table 1). Dia
Po/CSA, however, was
slightly lower (~8%) in CK[
/
] mice as
compared with Ctl (Table 1).
|
|||||||||||||||||||||||||||||||||||||||||||||
Isotonic contractile properties. Dia
force-velocity characteristics are also shown in Table 1. Mean
force-velocity data from Ctl and CK[
/
] groups
are shown in Fig. 1. Both groups manifested a hyperbolic force-velocity relationship (Fig. 1) with similar a/Po
values (Table 1).
Vmax, however,
was significantly lower (~19%) in CK[
/
]
Dia compared with Ctl Dia (Table 1, Fig. 1).
) and creatine kinase-deficient (CK[
/
];
) diaphragm (Dia). Both
groups manifested a hyperbolic force-velocity relationship with similar
a/Po
values (see Table 1). Maximum velocity of shortening was significantly
lower in CK[
/
] Dia compared with Ctl Dia.
Lo, optimal fiber
length.
Mean power-load data from control and CK[
/
]
groups are shown in Fig. 2. Power
manifested a parabolic pattern as a function of load, and maximum power
was generated at 0.4-0.5 Po
in both groups. Absolute maximum power, however, was lower in
CK[
/
] mice, as compared with Ctl Dia (Table
1, Fig. 2), reflecting the greater specific force generated by Ctl Dia
at all loads. Velocity of shortening at 40-50%
Po was not different between groups.
) and CK[
/
] (
)
Dia. Power manifested a parabolic pattern as a function of load.
Absolute maximum power was significantly lower in
CK[
/
] Dia compared with Ctl Dia.
Mean workload data from control and CK[
/
] Dia
are shown in Fig. 3. Similar to the
power-load relationship, work manifested a parabolic pattern as a
function of load, and maximum work was generated at 0.4-0.5
Po in both groups. Maximum work,
however, was lower in CK[
/
] Dia, as compared
with Ctl Dia, reflecting the greater
Po/CSA generated by the Ctl
Dia at all loads. The extent of Dia shortening at 40-50%
Po was not different between groups.
) and CK[
/
] (
)
Dia. Work manifested a parabolic pattern as a function of load.
Absolute maximum work was significantly lower in
CK[
/
] Dia compared with Ctl Dia.
The velocity and extent of muscle shortening, power, and work declined
significantly during repetitive isotonic activation in both Ctl and
CK[
/
] Dia (Fig.
4). The decline in power and work
associated with repetitive isotonic activation reflected significant
decreases in the velocity and extent of Dia shortening, respectively,
as force was clamped at 0.4 Po
during repetitive activation. The velocity and extent of shortening,
power, and work after the initial stimulus were significantly lower in
CK[
/
] as opposed to Ctl Dia (Fig. 4). These
differences were sustained throughout the period of repetitive isotonic
activation. Moreover, the endurance time of
CK[
/
] Dia (37 ± 4 s) was significantly less than that of control Dia (61 ± 5 s) (Fig. 4).
/
] (solid bars) Dia during repetitive
istonic activation. First stimulation and every other one thereafter
are shown until muscle failed to shorten. Significantly lower
velocities of shortening, power, length changes, and work were seen in
CK[
/
] as opposed to Ctl Dia after initial stimulus. Interval between initiation of repetitive isotonic activation and cessation of muscle shortening, i.e., endurance time, was significantly shorter in CK[
/
] as opposed to
Ctl Dia.
Total CK activity and isoenzyme
phenotype. Total CK activity was 801 ± 42 µmol · mg
protein
1 · min
1
in Ctl Dia and was composed of ~25% ScCKmit and 75% CK-MM isoforms. In contrast, total CK activity in CK[
/
] Dia
was 6.4 ± 0.3 µmol · mg
protein
1 · min
1,
averaging 0.8% of Ctl levels. Neither CK-M nor ScCKmit
isoforms were noted on CK zymogen gels of
CK[
/
] Dia, as opposed to abundant expression
of both isoforms in Ctl Dia (Fig. 5), and
we surmise residual CK activity to originate from immature satellite
cells and the smooth muscle lining of vasculature in this muscle.
/
] Dia. Neither M-CK nor ScCKmit
isoforms were noted in CK[
/
] Dia, as opposed
to abundant expression of both isoforms in Ctl Dia.
MHC phenotype. The MHC phenotypes of
Ctl and CK[
/
] Dia were comparable and
characterized by abundant
MHC2A and
MHC2X expression (Fig.
6). CK[
/
] Dia,
however, expressed significantly less
MHC2B and more
MHCslow than its wild-type
counterpart (Fig. 6).
/
] (solid bars) Dia. Specific MHC isoform
content is expressed as a relative %total MHC complement.
* P = 0.05, Ctl vs.
CK[
/
].
In vivo, the Dia shortens against a load, enlarging the chest cavity
and generating negative intrathoracic pressure and air movement into
the lungs. Thus two important functional properties of the Dia are
power and work. The present study demonstrates that combined
myofibrillar and sarcomeric mitochondrial CK deficiency is associated
with a profound impairment of Dia power output and work performance
during repetitive isotonic activation. These findings are consistent
with the lower
Vmax and slightly
reduced Po/CSA noted in
CK[
/
] Dia and underscore the importance of CK in respiratory muscle function.
Prior studies designed to assess the physiological role of CK in muscle
have utilized nonspecific inhibitors of total CK activity such as
dinitrofluorobenzene and iodoacetamide and suggest an important role
for CK in muscle energy metabolism (11). Substrate analogs of Cr, e.g.,
-guanidinopropionic acid (
-GPA), a poor substrate (higher
Michaelis constant and lower
Vmax) for CK,
have also been used to decrease PCr and ATP levels. Early studies on
-GPA-fed animals led to disparate results, with some investigations finding no effect of CK inhibition on skeletal muscle function (24) and
others reporting an impairment of muscle force generation during
repetitive activation (10, 16). More recent studies on
-GPA-fed
animals demonstrate a greater impairment of limb muscle isometric
force-generating capacity during the initial series of repetitive
activation, as compared with control muscle (17). Force generation
during the latter phases of repetitive activation, however, was
stabilized at control levels or even higher in
-GPA-fed animals
(17). Similar observations have been made in M-CK-deficient transgenic
mouse limb muscle (30, 31). In
-GPA-fed animals, the loss of
force-generating capacity during the early phase of activation likely
reflects their diminished skeletal PCr and ATP stores, whereas their
ability to sustain force during the latter phases of repetitive
activation mirrors skeletal muscle structural and biochemical
adaptations to chronic
-GPA exposure. Such adaptations include
1) type II fiber atrophy (23);
2) an increase in
MHCslow isoform expression (19);
3) an increase in mitochondrial
enzyme activity (23), and 4) a decrease in glycolytic potential (23). Analogous observations have been
reported in M-CK-deficient transgenic mouse limb muscle (27, 30, 31).
The aforementioned changes suggest that the skeletal muscle of
-GPA-fed animals is able to adapt, so as to activate pathways of
aerobic metabolism in response to a diminished creatine pool and
thereby preserve function, and have been interpreted as evidence of the
importance of CK in skeletal muscle high-energy metabolism.
In the present study, we used an alternative approach to examine the
role of CK in respiratory muscle function, i.e., ScCKmit/M-CK double-deficient mutant mice generated via targeted mutagenesis (27).
More specifically, mice bearing a null mutation of the ScCKmit gene
(27, 28) were interbred with mice bearing a null mutation of the M-CK
gene (32) to generate heterozygotes for both CK isoforms. Sibling
matings of these mice resulted in the generation of a
CK[
/
] double-deficient line (27).
Previous studies have explored the contractile and fatigue
characteristics of the medial gastrocnemius in wild-type,
M-CK-deficient (7, 27, 30, 31), ScCKmit-deficient (27, 28), and CK[
/
] double-deficient (27) transgenic mice.
These studies indicated no differences in
Pt, CT, or
RT1/2 of the twitch contractions among the four CK phenotypes (27). However, these studies suggested that CK might modulate the contractile response of the medial gastrocnemius during repetitive isometric (7, 27, 30, 31) or
isovelocity (7) activations. Medial gastrocnemius from M-CK-deficient and CK[
/
] double-deficient mice
failed to sustain twitch and tetanic force production during the early
phase of repetitive activation, while forces stabilized at the same
level as controls during the latter stages of repetitive contraction.
The absence of ScCKmit alone was not associated with any significant
change in force generation during any stage of repetitive isometric
activation as compared with control muscle (27, 28), suggesting that the absence of M-CK accounted for the impairment in function of CK[
/
] medial gastrocnemius. Indeed, a recent
study of transgenic mouse mutants with graded reductions in M-CK
activity showed a strong positive correlation between the level of M-CK
expression in limb muscle and the ability to maintain maximal muscle
force during the initial phase of isometric activation (31).
In contrast, in preliminary studies, we were unable to demonstrate that M-CK deficiency alone was associated with any greater impairment in Dia force-generating capacity than control Dia during repetitive isometric twitch or tetanic stimulation (13). This discrepancy may relate to the relatively abundant expression of ScCKmit in the Dia [~25% of the total CK phenotype (34)], as opposed to medial gastrocnemius muscle (1-2% of the total CK phenotype). The enhanced expression of ScCKmit in the Dia may provide sufficient ATP-buffering capacity to counter the effects of isolated myofibrillar CK deficiency in the M-CK-deficient transgenic Dia. We, therefore, sought to determine the effect of combined M-CK and ScCKmit deficiency on Dia function and to do so within the context of repetitive dynamic activation where metabolic demands would be highest (9). Indeed, the repetitive isotonic activation protocol used in the present study creates a condition that emphasizes the role of CK in meeting the energy demands of contraction, although it may not strictly mimic the normal physiological situation.
Isometric twitch characteristics were not different between
CK[
/
] and Ctl Dia. In contrast,
Po/CSA was significantly
lower in CK[
/
] Dia as compared with Ctl Dia.
The mechanism underlying the slight reduction of
Po/CSA in
CK[
/
] Dia was not addressed by the present
study, but this finding is consistent with the aforementioned
observations on CK[
/
] limb muscle (medial
gastrocnemius) (27) and
-GPA-treated rats (16).
The present study was the first to examine the effect of CK deficiency
on the force-velocity relationship of the Dia. We observed a
significantly lower
Vmax in
CK[
/
] as opposed to Ctl Dia. The curvature of
the force-velocity relationship as quantified by a/Po,
however, was not different between study groups.
Vmax is highly
correlated with the rate of ATP hydrolysis (actomyosin ATPase activity)
by the MHC (4) and reflects the maximal cross-bridge cycling rate. The
mechanism underlying the lower
Vmax in
CK[
/
] Dia may relate in part to the
alteration in MHC phenotype of the Dia in response to combined CK-M and
ScCKmit deficiency, i.e., an increased
MHCslow and diminished
MHC2B expression. This shift in
MHC isoform expression, also observed in
-GPA-treated animals (19),
might be expected to decrease the overall actomyosin ATPase activity of
the CK[
/
] Dia, as well as cross-bridge
cycling rate and
Vmax. However,
the difference in MHC isoform expression between Ctl and
CK[
/
] Dia was relatively small and,
therefore, unlikely to fully account for the difference in
Vmax. Other
possible contributing factors to the difference in
Vmax between Ctl
and CK[
/
] Dia include alterations in
regulatory contractile protein isoforms, i.e., alkaline myosin light
chain composition (5) and troponin. Additional investigation is
necessary to clarify this issue.
The CK[
/
] Dia was less able to sustain power
(shortening velocity) and work (extent of shortening) during repetitive
isotonic activation, compared with Ctl Dia. Shortening velocity and the extent of shortening were already significantly depressed in the second
series of isotonic activation, and this depression was persistent
throughout the period of repetitive stimulation. The rapidity of this
decline was marked and consistent with previous reports on
CK[
/
] limb muscle during repetitive
activation (27). Moreover, the interval between the initiation of
repetitive isotonic activation and the cessation of muscle shortening,
i.e., endurance time, was significantly shorter in
CK[
/
] as opposed to Ctl Dia. The initial
cross-bridge cycling rates did not differ between Ctl and
CK[
/
] Dia at the afterload used during the
repetitive isotonic activation paradigm, indicating that the rate of
ATP consumption should be similar between groups at the start of the endurance protocol. The subsequent rapid decline in power and work
output of CK[
/
] as opposed to control Dia
during repetitive isotonic activation likely reflects the high
energetic demands of dynamic contractions and the impaired
ATP-buffering capacity of CK[
/
] Dia. The
latter may limit actomyosin ATPase activity with a resultant decrease
in cross-bridge cycling rate, velocity of shortening, and power in
CK[
/
] Dia.
The decreased velocity of shortening may also relate to intracellular
metabolic changes during repetitive isotonic activation that could be
accentuated in CK[
/
] Dia. More
specifically, the accumulation of metabolites during repetitive muscle
activation such as MgADP and hydrogen ions have been shown to impair
the kinetic properties of skinned muscle fibers (1, 6, 8), and the
concentration of these products should be enhanced in the absence of CK
ATP-buffering capacity. On the basis of measurements of the
Vmax of diaphragm
actomyosin ATPase activity (26), ~0.8 µmol of ATP/g tissue should
be hydrolyzed during 330 ms of isotonic activation. Without adequate CK
buffering of ADP, this would cause a large increase in ADP
concentration after even one contraction. Analogous calculations by
others suggest that, in the absence of CK buffering, ADP concentrations
rise during muscle activation to levels that significantly reduce the
shortening velocity of skinned fibers in vitro (1, 6). Finally,
although there is only limited evidence to indicate that myoplasmic
free calcium concentration influences shortening velocity (1), we have
recently observed that CK[
/
] Dia has
distinctly altered calcium release and sequestration characteristics
(unpublished observations) during repetitive activation that may have
profound effects on the excitation-contraction profile of this muscle.
Additional investigation is necessary to clarify which factor or
combination of factors is primarily responsible for the marked decline
in power output and work performance in CK[
/
]
Dia during repetitive isotonic activation.
In summary, the results of the present study demonstrate that combined
ScCKmit/M-CK deficiency is associated with
1) a slight decrease in
Po/CSA,
2) a decrease in
Vmax,
3) a decrease in maximum power and
work, and 4) a profound impairment
of Dia shortening capacity during repetitive isotonic activation, as
compared with wild-type Ctl. Both the extent and velocity of Dia
shortening during repetitive isotonic activation in
CK[
/
] Dia were markedly diminished,
leading to significantly greater declines in power output and work
performance over time as compared with Ctl. These findings underscore
the functional importance of CK in skeletal muscle.
The present study was supported by a Career Investigator Award from the American Lung Association (to J. F. Watchko) and the Wyeth Pediatrics Neonatology Research Grants Program (to J. J. LaBella). The authors thank Y. S. Prakash for invaluable technical assistance in this study.
Address for reprint requests: G. C. Sieck, Anesthesia Research, Mayo Clinic, Rochester, MN 55905.
Address for correspondence: J. F. Watchko, Dept. of Pediatrics, Magee-Women's Hospital, 300 Halket St., Pittsburgh, PA 15213.
Received 30 September 1996; accepted in final form 30 December 1996.
| 1. | Allen, D. G., J. Lannergren, and H. Westerblad. Muscle cell function during prolonged activity: cellular mechanisms of fatigue. Exp. Physiol. 80: 497-527, 1995 [Abstract] . |
| 2. |
Ameredes, B. T.,
W. F. Brechue,
G. M. Andrew,
and
W. N. Stainsby.
Force-velocity shifts with repetitive isometric and isotonic contractions of canine gastrocnemius in situ.
J. Appl. Physiol.
73:
2105-2111,
1992
|
| 3. |
Ameredes, B. T.,
and
T. L. Clanton.
Increased fatigue of isovelocity vs. isometric contractions of canine diaphragm.
J. Appl. Physiol.
69:
740-746,
1990
|
| 4. | Barany, M. ATPase activity of myosin correlated with speed of muscle shortening. J. Gen. Physiol. 50, Suppl.: 197-218, 1967. |
| 5. | Bottinelli, R., R. Betto, S. Schiaffino, and C. Reggiani. Unloaded shortening velocity and myosin heavy chain and alkali light chain isoform composition in rat skeletal muscle fibres. J. Physiol. (Lond.) 478: 341-349, 1994 [Medline] . |
| 6. |
Cooke, R.,
and
E. Pate.
The effects of ADP and phosphate on the contraction of muscle fibers.
Biophys. J.
48:
789-798,
1985
|
| 7. | De Haan, A., J. C. M. Koudijs, R. A. Wevers, and B. Wieringa. The effects of MM-creatine kinase deficiency on sustained force production of mouse fast skeletal muscle. Exp. Physiol. 80: 491-494, 1995 [Abstract] . |
| 8. | Edman, K. A. P., and A. Mattiazzi. Effects of fatigue and altered pH on isometric force and velocity of shortening at zero load in frog muscle fibres. J. Muscle Res. Cell Motil. 2: 321-334, 1981. [Medline] |
| 9. | Fenn, W. O. The relation between the work performed and the energy liberated in muscular contraction. J. Physiol. (Lond.) 58: 373-395, 1924. |
| 10. |
Fitch, C. D.,
M. Jellinek,
R. H. Fitts,
K. M. Baldwin,
and
J. O. Holloszy.
Phosphorylated -guanidinoproprionate as a substitute for phosphocreatine in rat muscle.
Am. J. Physiol.
228:
1123-1125,
1975
.
|
| 11. |
Fossel, E. T.,
and
H. Hoefeler.
Complete inhibition of creatine kinase in isolated perfused rat hearts.
Am. J. Physiol.
252 (Endocrinol. Metab. 15):
E124-E130,
1987
|
| 12. | Hill, A. V. The heat of shortening and dynamic constants of muscle. Proc. R. Soc. Lond. Ser. B 126: 136-195, 1938. |
| 13. | LaBella, J. J., B. Wieringa, A. P. Koretsky, M. J. Daood, and J. F. Watchko. Fatigue resistance and myosin heavy chain phenotype of diaphragm from mice deficient in muscle creatine kinase (Abstract). Am. J. Respir. Crit. Care Med. 151: A479, 1995. |
| 14. | LaFramboise, W. A., M. J. Daood, R. D. Guthrie, S. Schiaffino, P. Moreti, B. S. Brozanski, M. P. Ontell, G. S. Butler-Browne, R. G. Whalen, and M. Ontell. Emergence of the mature myosin phenotype in the rat diaphragm muscle. Dev. Biol. 144: 1-15, 1991 [Medline] . |
| 15. |
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr,
and
R. J. Randall.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:
265-272,
1951.
|
| 16. | Mainwood, G. W., M. Alward, and B. Eiselt. Contractile characteristics of creatine-depleted rat diaphragm. Can. J. Physiol. Pharmacol. 60: 120-127, 1982 [Medline] . |
| 17. |
Meyer, R. A.,
T. R. Brown,
B. L. Krilowicz,
and
M. J. Kushmerick.
Phosphagen and intracellular pH changes during contraction of creatine-depleted rat muscle.
Am. J. Physiol.
250 (Cell Physiol. 19):
C264-C274,
1986
|
| 18. |
Meyer, R. A.,
H. L. Sweeney,
and
M. J. Kushmerick.
A simple analysis of the "phosphocreatine shuttle."
Am. J. Physiol.
246 (Cell Physiol. 15):
C365-C377,
1984
|
| 19. |
Moerland, T. S.,
N. G. Wolf,
and
M. J. Kushmerick.
Administration of a creatine analogue induces isomyosin transitions in muscle.
Am. J. Physiol.
257 (Cell Physiol. 26):
C810-C816,
1989
|
| 20. | Petrofsky, J. S., and C. D. Fitch. Contractile characteristics of skeletal muscles depleted of phosphocreatine. Pflügers Arch. 384: 123-129, 1980 [Medline] . |
| 21. | Ryan, B. F., B. L. Joiner, and T. A. Ryan. Minitab. Boston, MA: Duxbury, 1985, p. 193-217, 292-299. |
| 22. |
Seow, C. Y.,
and
N. L. Stephens.
Fatigue of mouse diaphragm muscle in isometric and isotonic contractions.
J. Appl. Physiol.
64:
2388-2393,
1988
|
| 23. |
Shoubridge, E. A.,
R. A. J. Challiss,
D. J. Hayes,
and
G. K. Radda.
Biochemical adaptation in the skeletal muscle of rats depleted of creatine with the substrate analogue -guanidinopropionic acid.
Biochem. J.
232:
125-131,
1985
[Medline]
.
|
| 24. |
Shoubridge, E. A.,
and
G. K. Radda.
A 31P-nuclear magnetic resonance study of skeletal muscle metabolism in rats depleted of creatine with the analogue -guanidinopropionic acid.
Biochim. Biophys. Acta
805:
79-88,
1984
[Medline]
.
|
| 25. | Sieck, G. C., and M. Fournier. Developmental aspects of diaphragm muscle cells: structural and functional organization. In: Developmental Neurobiology of Breathing, edited by G. G. Haddad, and J. P. Farber. New York: Dekker, 1991, vol. 53, p. 375-428. (Lung Biol. Health Dis. Ser.) |
| 26. |
Sieck, G. C.,
W. Z. Zhan,
Y. S Prakash,
M. J. Daood,
and
J. F. Watchko.
SDH and actomyosin ATPase activities of different fiber types in rat diaphragm muscle.
J. Appl. Physiol.
79:
1629-1639,
1995
|
| 27. | Steeghs, K., A. Heerschap, A. de Haan, W. Ruitenbeek, F. Oerlemans, J. van Deursen, B. Perryman, D. Pette, H. Croes, M. Bruckwilder, J. Koudijs, P. Jap, and B. Wieringa. Muscles with combined mitochondrial and cytosolic creatine kinase deficiencies display hyperproliferative sarcoplasmic reticulum and severely impaired force generation. In: Consequences of Creatine Kinase Deficiencies in Mice (PhD thesis). Nijmegen, The Netherlands: Univ. of Nijmegen, 1995, p. 93-123. |
| 28. | Steeghs, K., A. Heerschap, A. de Haan, W. Ruitenbeek, F. Oerlemans, J. van Deursen, B. Perryman, D. Pette, M. Bruckwilder, J. Koudijs, and B. Wieringa. Use of gene targeting for compromising energy homeostasis in neuromuscular tissues: the role of sarcomeric mitochondrial creatine kinase. J. Neurosci. Method. In press. |
| 29. |
Talmadge, R. J.,
and
R. R. Roy.
Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms.
J. Appl. Physiol.
75:
2337-2340,
1993
|
| 30. | Van Deursen, J., A. Heerschap, F. Oerlemans, W. Ruitenbeek, P. Jap, H. ter Laak, and B. Wieringa. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 74: 621-631, 1993 [Medline] . |
| 31. |
Van Deursen, J.,
W. Ruitenbeek,
A. Heerschap,
P. Jap,
H. ter Laak,
and
B. Wieringa.
Creatine kinase in skeletal muscle energy metabolism: a study of mouse mutants with graded reduction in M-CK expression.
Proc. Natl. Acad. Sci. USA
91:
9091-9095,
1994
|
| 32. |
Van Deursen, J.,
and
B. Wieringa.
Targeting of the creatine kinase M gene in embryonic stem cells using isogenic and nonisogenic vectors.
Nucl. Acids Res.
20:
3815-3820,
1992
|
| 33. | Wallimann, T., M. Wyss, D. Brdiczka, K. Nicolay, and H. M. Eppenberger. Intracellular compartmentalization, structure, and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostasis. Biochem. J. 281: 21-40, 1992 . |
| 34. | Watchko, J. F., M. J. Daood, and John J. LaBella. Creatine kinase activity in rat skeletal muscle relates to myosin phenotype during development. Pediatr. Res. 40: 53-58, 1996 [Medline] . |
| 35. |
Watchko, J. F.,
and
G. C. Sieck.
Respiratory muscle fatigue resistance relates to myosin phenotype and SDH activity during development.
J. Appl. Physiol.
75:
1341-1347,
1993
|
| 36. | Zar, J. H. Biostatistical Analysis (2nd ed.). Englewood Cliffs, NJ: Prentice-Hall, 1984, p. 185-205. |
This article has been cited by other articles:
![]() |
E. van Lunteren, J. Pollarine, and M. Moyer Muscle: Isotonic contractile impairment due to genetic CLC-1 chloride channel deficiency in myotonic mouse diaphragm muscle Exp Physiol, July 1, 2007; 92(4): 717 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Momken, P. Lechene, N. Koulmann, D. Fortin, P. Mateo, B. T. Doan, J. Hoerter, X. Bigard, V. Veksler, and R. Ventura-Clapier Impaired voluntary running capacity of creatine kinase-deficient mice J. Physiol., June 15, 2005; 565(3): 951 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lecarpentier, D. Chemla, J. C. Pourny, F.-X. Blanc, and C. Coirault Myosin cross bridges in skeletal muscles: "rower" molecular motors J Appl Physiol, December 1, 2001; 91(6): 2479 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Shulman and D. L. Rothman The "glycogen shunt" in exercising muscle: A role for glycogen in muscle energetics and fatigue PNAS, January 16, 2001; 98(2): 457 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. DAHLSTEDT, A. KATZ, B. WIERINGA, and H. WESTERBLAD Is creatine kinase responsible for fatigue? Studies of isolated skeletal muscle deficient in creatine kinase FASEB J, May 1, 2000; 14(7): 982 - 990. [Abstract] [Full Text] |
||||
![]() |
M. Vendelin, O. Kongas, and V. Saks Regulation of mitochondrial respiration in heart cells analyzed by reaction-diffusion model of energy transfer Am J Physiol Cell Physiol, April 1, 2000; 278(4): C747 - C764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Watchko, M. J. Daood, B. Wieringa, and A. P. Koretsky Myofibrillar or mitochondrial creatine kinase deficiency alone does not impair mouse diaphragm isotonic function J Appl Physiol, March 1, 2000; 88(3): 973 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Tankersley, C. O'Donnell, M. J. Daood, J. F. Watchko, W. Mitzner, A. Schwartz, and P. Smith Leptin attenuates respiratory complications associated with the obese phenotype J Appl Physiol, December 1, 1998; 85(6): 2261 - 2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Labella, M. J. Daood, A. P. Koretsky, B. B. Roman, G. C. Sieck, B. Wieringa, and J. F. Watchko Absence of myofibrillar creatine kinase and diaphragm isometric function during repetitive activation J Appl Physiol, April 1, 1998; 84(4): 1166 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Roman, B. Wieringa, and A. P. Koretsky Functional Equivalence of Creatine Kinase Isoforms in Mouse Skeletal Muscle J. Biol. Chem., July 11, 1997; 272(28): 17790 - 17794. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||